Literature DB >> 16916493

Surgical approach to the patient with familial hyperparathyroidism.

Lindi H VanderWalde1, Philip I Haigh.   

Abstract

Familial hyperparathyroidism encompasses the diagnoses of multiple endocrine neoplasia (MEN) type 1, MEN type 2A, and familial isolated primary hyperparathyroidism. All patients should undergo bilateral neck exploration and identification of all four or more parathyroid glands to evaluate for gross abnormalities. MEN-1 patients should have subtotal parathyroidectomy and cervical thymectomy because this operation achieves an appropriate balance between optimizing the potential for cure yet minimizing the risk of permanent hypocalcemia. However, MEN-2A patients may best be treated by selective resection of abnormal parathyroid glands, although some experts recommend a total parathyroidectomy and autotransplantation in the forearm. Familial isolated hyperparathyroidism is a rare disorder, and authors have described success in treatment with subtotal parathyroidectomy or limited adenoma resections. Some patients with familial isolated hyperparathyroidism also have jaw tumors, and members of these families are more likely to have parathyroid carcinoma. Concurrent cryopreservation of parathyroid tissue for all of these disorders is recommended if there is any concern for possible permanent hypoparathyroidism.

Entities:  

Mesh:

Year:  2006        PMID: 16916493     DOI: 10.1007/s11864-006-0042-5

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  30 in total

1.  The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred.

Authors:  B M Cavaco; L Barros; A A Pannett; L Ruas; M Carvalheiro; M M Ruas; T Krausz; M A Santos; L G Sobrinho; V Leite; R V Thakker
Journal:  QJM       Date:  2001-04

2.  A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.

Authors:  C J Haven; F K Wong; E W van Dam; R van der Juijt; C van Asperen; J Jansen; C Rosenberg; M de Wit; J Roijers; J Hoppener; C J Lips; C Larsson; B T Teh; H Morreau
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

3.  Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?

Authors:  C Dotzenrath; K Cupisti; P E Goretzki; Q Yang; D Simon; C Ohmann; H D Röher
Journal:  Eur J Surg       Date:  2001-03

4.  Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Authors:  Laura A Lambert; Suzanne E Shapiro; Jeffrey E Lee; Nancy D Perrier; Mylene Truong; Michael J Wallace; Ana O Hoff; Robert F Gagel; Douglas B Evans
Journal:  Arch Surg       Date:  2005-04

5.  A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy.

Authors:  T Horiuchi; T Onouchi; J Inoue; A Shionoiri; T Hosoi; H Orimo
Journal:  Gerontology       Date:  2002 Mar-Apr       Impact factor: 5.140

6.  Multiple endocrine neoplasia type 1 parathyroid adenoma development over time.

Authors:  Gerard M Doherty; Terry C Lairmore; Mary K DeBenedetti
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

7.  Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.

Authors:  K K Herfarth; D Bartsch; G M Doherty; S A Wells; T C Lairmore
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

8.  Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Authors:  Aliya A Khan; John P Bilezikian; Annie W C Kung; Mustafa M Ahmed; Sacha J Dubois; Andrew Y Y Ho; Debra Schussheim; Mishaela R Rubin; Atif M Shaikh; Shonni J Silverberg; Timothy I Standish; Zareen Syed; Zeba A Syed
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

Authors:  J Warner; M Epstein; A Sweet; D Singh; J Burgess; S Stranks; P Hill; D Perry-Keene; D Learoyd; B Robinson; P Birdsey; E Mackenzie; B T Teh; J B Prins; J Cardinal
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

View more
  4 in total

1.  Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Authors:  Naris Nilubol; Lee Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 2.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature.

Authors:  Nikolaos Pontikides; Spyridon Karras; Athina Kaprara; Panagiotis Anagnostis; Gesthimani Mintziori; Dimitrios G Goulis; Eleni Memi; Gerasimos Krassas
Journal:  J Bone Miner Metab       Date:  2014-01-19       Impact factor: 2.626

Review 4.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.